GlaxoSmithKline Uses RFID To Check Circulation of Counterfeit Medicines
The complexity of the supply chain often makes it easier for criminals to circulate counterfeit products in the market. To check this, GlaxoSmithKline , a Philadelphia-based pharmaceutical firm would soon start using RFID tags to check counterfeiting of Triziver, an HIV medication.
Triziver falls in the first 32 in the list of most commonly counterfeited drugs prepared by the National Association of Boards. To ensure that the medicine is distributed through the appropriate channels, each bottle of the medicine would have an RFID tag. This would also help in determining the origin of the medication.
These tags have been developed in association with IBM. The Food and Drug Administration is directing all pharmaceutical companies to start using RFID tags to ensure that no counterfeit medicines are circulated in the market.
Subscribe to the comments for this post